SPI Infoamtion

Table of Contents

Executive summary

Market overview
Healthcare nanotechnology market dynamics
Nanomaterials & nanotools for the healthcare market
Healthcare nanotechnology application market
Company profiles

Chapter 1 Market overview

Summary
Introduction

Market definition
Healthcare nanotechnology business processes

Healthcare nanotechnology applications

Healthcare nanotechnology application prospects

Opportunity matrix
Challenge matrix

Patent analysis

Chapter 2 Healthcare nanotechnology market dynamics

Summary
Introduction
Regional markets

North America
Europe
Asia
RoW

Competitive landscape

R&D activities by applications
New product launches
Collaborations & agreements

Market drivers

Nanotechnology research initiatives in developing nations
Innovations are increasing
Reduced toxicity

Market inhibitors

Delay in commercialization
Stability and other issues
Need for particle evaluation

Chapter 3 Nanomaterials & nanotools for the healthcare market

Summary
Introduction
Nanomaterials

Nanocapsules

Drivers
Inhibitors
Opportunities

Nanoporous materials

Drivers
Opportunities

Quantum dots

Drivers
Inhibitors
Opportunities

Nanotubes

Drivers

Nanowires

Drivers
Inhibitors
Opportunities

Dendrimers

Drivers
Opportunities

Monoclonal antibodies

Drivers
Inhibitors
Opportunities

Nanocomposites
Fullerenes
Nanofilms

Drivers
Inhibitors
Opportunities

Nanotools

Nanoarrays

Drivers
Inhibitors
Opportunities

Nanobiochip

Drivers
Opportunities

Nanolithography arrays

Drivers
Inhibitors
Opportunities

Computer-assisted drug discovery
Nanomass spectrometry

Drivers
Inhibitors
Opportunities

Congruent Force Intermolecular Test (nanotype) C-FIT

Chapter 4 Healthcare nanotechnology application market

Summary
Introduction
Drug formulation and delivery

Formulation

Drivers
Inhibitors
Opportunities
Fluorescently encoded microparticles
Nanoparticulate formulation/systems
Fluoropolymers as material platforms for drug therapy
DNA nanoparticle technology to produce DNA drugs
Drug profiling using smart materials
Supercritical fluids and water based nanomaterials
Dendrimer nanotechnology products
Potential healthcare nanotechnology drug formulation application

Drug delivery

Drivers
Inhibitors
Opportunities
Nanoencapsulation using nano-device platform
Smart materials for encapsulation
Antimicrobial nanoencapsulation
Nanoscale cochlear drug delivery
Drug delivery using nanoparticles
Nanocrystals for drug delivery
Drug delivery coatings
Nanopores
Nanocomposites
Nanotransponders
Potential applications of healthcare nanotechnology drug delivery

Biocompatible implants and coatings

Drivers

Nanofibers fight immune response
Improvement in biocompatibility
Optimized coatings
Improvement in dental implants

Inhibitors

Improvement of implant depends upon coatings
Possibility of mass poisoning

Opportunities

Improved brain implants
Improvement in process for better coatings
Helpful in orthopedic devices

Surface modification
Device coating

Drivers
Inhibitors
Opportunities
Sol-gel coatings
Biocompatible nanocoatings
Nanoscale plasma coating
Light-activated antimicrobials
Silver nanoparticles
Hydrophobic coatings
Multifunctional coatings
Anti-fouling nanocoatings
Passive hydroxyapatite coating
Other protective coatings

Implants

Drivers
Opportunities

Potential biocompatible implants applications

Life support devices using novel biocompatible polymers
Stimulation electrodes using nanotechnology
Noninvasive killing of cancer cells using localized heat
Artificial vascular grafts
Bone graft substitutes

Regenerative medicine and wound care

Regenerative medicine/tissue engineering

Drivers
Inhibitors
Opportunities
Potential applications of regenerative medicines

Wound care

Drivers
Opportunities
Nanosilver gels
Nanogold gels

Diagnostics

Drivers

Improved bioassays
Earlier diagnosis and effective monitoring

Opportunities

Treatment of ovarian cancer
Development of immunoassays

Quantum dots applications
Nanoemulsions in multimodal molecular imaging and targeted therapeutics
Nanoparticles for biochemical applications
Magnetic nanoparticles for medical diagnostic imaging
Encapsulation of radioactive nanoparticle
Genome sequencing
Nanobiosensors
Nanoarray biochips
Silicon-based chips/sensors for pH and pressure
Micro- and nano-replication for point-of-use analytical applications
Nanocells
Redox enzymes
Other potential diagnostics applications

Smart card diagnostics
Novel microfluidic technologies

Chapter 5 Company profiles

Summary
Abraxis BioScience, Inc.

Company overview
Products and services
Company strategy

Access Pharmaceuticals, Inc.

Company overview
Products and services
Company strategy

AstraZeneca

Company overview
Products and services
Company strategy

AMAG Pharmaceuticals, Inc.

Company overview
Products and services
Company strategy

Aphios Corp.

Company overview
Products and services
Company strategy

Asklepios Biopharmaceutical Inc.

Company overview
Products and services
Company strategy

Capsulution Nanoscience AG

Company overview
Products and services
Company strategy

ConvaTec

Company overview
Products and services
Company strategy

Debiotech

Company overview
Products and services
Company strategy

Do-Coop Technologies Ltd.

Company overview
Products and services
Company strategy

Elan Corp.

Company overview
Products and services
Company strategy

Ferro Corp.

Company overview
Products and services
Company strategy

Flamel Technologies

Company overview
Products and services
Company strategy

GE Global Research

Company overview
Company strategy

GfE Medizintechnik GmbH

Company overview
Products and services
Company strategy

HemCon Medical Technologies, Inc.

Company overview
Company strategy

iCeutica Inc

Company overview
Products and services
Company strategy

Liquidia Technologies

Company overview
Company strategy

Luna Innovations Inc.

Company overview
Products and services
Company strategy

MagForce Nanotechnologies AG

Company overview
Products and services
Company strategy

Merck KGaA

Company overview
Products and services
Company strategy

MIV Therapeutics Inc

Company overview
Products and services
Company strategy

Nanomix

Company overview
Products and services
Company strategy

Nano Interface Technology, Inc

Company overview
Products and services
Company strategy

NanoCarrier Co., Ltd.

Company overview
Products and services
Company strategy

NanoDel Technologies

Company overview
Products and services
Company strategy

NanoHorizons Inc.

Company overview
Products and services
Company strategy

Nanoprobes, Inc.

Company overview
Products and services
Company strategy

Nanospectra Biosciences Inc.

Company overview
Products and services
Company strategy

Nanosphere, Inc.

Company overview
Products and services
Company strategy

Novartis AG

Company overview
Products and services
Company strategy

Pfizer

Company overview
Company strategy

PharmaSol GmbH

Company overview
Products and services
Company strategy

Pioneer Surgical Technology

Company overview
Products and services
Company strategy

pSivida

Company overview
Products and services
Company strategy

F. Hoffmann-La Roche Ltd.

Company overview
Products and services
Company strategy

Siemens Medical Solutions

Company overview
Products and services
Company strategy

Smith & Nephew

Company overview
Products and services
Company strategy

Starpharma Holdings Ltd.

Company overview
Products and services
Company strategy

T2 Biosystems Inc.

Company overview
Company strategy

Appendix

Patents
Glossary

List of Figures
Figure 1.1: Global healthcare nanotechnology market
Figure 1.2: Geographical patent share, 2003-08
Figure 1.3: Number of patents by region, 2003-09
Figure 1.4: Comparison of patent trends, 2004 vs 2009
Figure 2.5: Developmental strategies by major players, January 2007-November 2009
Figure 2.6: R&D activities by applications, Jan 2007-Nov 2009
Figure 2.7: New product launches, Jan 2007-Nov 2009
Figure 2.8: Collaborations & agreements by applications, Jan 2007-Nov2009
Figure 2.9: Relative importance of features of healthcare nanotechnology

List of Tables
Table 2.1: Global healthcare nanotech market, by geography ($m), 2007-14
Table 2.2: Mergers & acquisitions in healthcare nanotech market, 2007-09
Table 2.3: New product launches in healthcare nanotech market, 2007-09
Table 2.4: New product launches in healthcare nanotech market, 2007-09 (ctd)
Table 2.5: R&D in healthcare nanotech market, 2007-09
Table 2.6: R&D in healthcare nanotech market, 2007-09 (ctd 1)
Table 2.7: R&D in healthcare nanotech market, 2007-09 (ctd 2)
Table 2.8: R&D in healthcare nanotech market, 2007-09 (ctd 3)
Table 2.9: R&D in healthcare nanotech market, 2007-09 (ctd 4)
Table 2.10: R&D in healthcare nanotech market, 2007-09 (ctd 5)
Table 2.11: R&D in healthcare nanotech market, 2007-09 (ctd 6)
Table 2.12: Collaborations & agreements in healthcare nanotech market, 2007-09
Table 2.13: Collaborations & agreements in healthcare nanotech market, 2007-09 (ctd)
Table 4.14: Global healthcare nanotech drug formulation and delivery market, by product ($m), 2007-14
Table 4.15: Global healthcare nanotech drug formulation and delivery market, by geography ($m), 2007-14
Table 4.16: Global healthcare nanotechnology drug formulation market, by product ($m), 2007-14
Table 4.17: Global healthcare nanotech fluorescently encoded microparticles market, by geography ($m), 2007-14
Table 4.18: Global healthcare nanotech nanoparticulate formulation/systems market, by geography ($m), 2007-14
Table 4.19: Global healthcare nanotech fluoropolymers material platforms for drug therapy market, by geography ($m), 2007-14
Table 4.20: Global healthcare DNA nanoparticle technology to produce DNA drugs market, by geography ($m), 2007-14
Table 4.21: Global healthcare nanotech drug profiling using smart materials market, by geography ($m), 2007-14
Table 4.22: Global healthcare nanotech supercritical fluids and water based nanomaterials market, by geography ($m), 2007-14
Table 4.23: Global dendrimer nanotech products market by geography ($m), 2007-14
Table 4.24: Global healthcare nanotech drug delivery market by product ($m), 2007-14
Table 4.25: Global healthcare nanoencapsulation using nano-device platform market, by product ($m), 2007-14
Table 4.26: Global healthcare nanoencapsulation using nano-device platform market, by geography ($m), 2007-14
Table 4.27: Global market for smart materials encapsulating pharmaceuticals, by geography ($m), 2007-14
Table 4.28: Global healthcare nanotech antimicrobial nanoencapsulation, by geography ($m), 2007-14
Table 4.29: Global healthcare nanotech nanoscale cochlear drug delivery, by geography ($m), 2007-14
Table 4.30: Global healthcare nanotech drug delivery using nanoparticles market, by product ($m), 2007-14
Table 4.31: Global healthcare nanotech drug delivery using nanoparticles market, by geography ($m), 2007-14
Table 4.32: Global drug delivery using nanocrystals market, by geography ($m), 2007-14
Table 4.33: Global healthcare nanotech drug delivery coatings market, by geography ($m), 2007-14
Table 4.34: Global healthcare nanopores market, by geography ($m), 2007-14
Table 4.35: Global healthcare nanocomposites market, by geography ($m), 2007-14
Table 4.36: Global healthcare nanotech nanotransponder market, by geography ($m), 2007-14
Table 4.37: Global healthcare nanotech biocompatible implants and coatings market, by products ($m), 2007-14
Table 4.38: Global healthcare nanotech biocompatible implants and coatings market, by geography ($m), 2007-14
Table 4.39: Global healthcare nanotech surface modification market, by geography ($m), 2007-14
Table 4.40: Global healthcare nanotech device coating market, by products ($m), 2007-14
Table 4.41: Global healthcare nanotech device coating market, by geography ($m), 2007-14
Table 4.42: Global healthcare nanotech implants market, by geography ($m), 2007-14
Table 4.43: Global healthcare nanotech regenerative medicine and wound care market, by products ($m), 2007-14
Table 4.44: Global healthcare nanotech regenerative medicine market, by product ($m), 2007-14
Table 4.45: Global healthcare nanotech wound care market, by products ($m), 2007-14
Table 4.46: Global healthcare nanotech diagnostics market, by products ($m), 2007-14
Table 4.47: Global healthcare nanotech diagnostics market, by geography ($m), 2007-14
Table 0.48: US patents
Table 0.49: US patents (ctd 1)
Table 0.50: US patents (ctd 2)
Table 0.51: US patents (ctd 3)
Table 0.52: US patents (ctd 4)
Table 0.53: US patents (ctd 5)
Table 0.54: US patents (ctd 6)
Table 0.55: US patents (ctd 7)
Table 0.56: US patents (ctd 8)
Table 0.57: US patents (ctd 9)
Table 0.58: US patents (ctd 10)
Table 0.59: US patents (ctd 11)
Table 0.60: US patents (ctd 12)
Table 0.61: US patents (ctd 13)
Table 0.62: US patents (ctd 14)
Table 0.63: US patents (ctd 15)
Table 0.64: US patents (ctd 16)
Table 0.65: US patents (ctd 17)
Table 0.66: US patents (ctd 18)
Table 0.67: US patents (ctd 19)
Table 0.68: Europe patents
Table 0.69: Europe patents (ctd 1)
Table 0.70: Europe patents (ctd 2)
Table 0.71: Europe patents (ctd 3)
Table 0.72: Europe patents (ctd 4)
Table 0.73: Europe patents (ctd 5)
Table 0.74: Europe patents (ctd 6)
Table 0.75: Europe patents (ctd 7)
Table 0.76: Europe patents (ctd 8)
Table 0.77: Europe patents (ctd 9)
Table 0.78: Europe patents (ctd 10)
Table 0.79: Europe patents (ctd 11)
Table 0.80: Japan patents
Table 0.81: Japan patents (ctd 1)